Veritas Intercontinental Revenue and Competitors

Veritas Europe & Latam is the Joint Venture created by Veritas Genetics (the Genome Company) and other local partners to develop the operations in Europe and Latin America. Veritas was founded in 2014 by leaders in genomics from Harvard Medical School, the company has been recognized twice by MIT Technology Review as one of the 50 Smartest Companies in 2016 and 2017; CNBC one of the 50 disruptor companies in 2018 and Fast Company one of the Most Innovative Companies in 2018. SEQUENCING YOUR GENOME IS THE FIRST STEP IN A LIFE-CHANGING JOURNEY... Veritas Europe & Latam is founded in 2018 and seeks to introduce advanced Genetics services around Whole Exome and Whole Genome Sequencing (WES/WGS) in Europe, Latin America and Middle East. Our mission is to deliver on the promise of the human genome, empowering people to maximize quality and length of life for themselves and their families. Veritas Genetics, as the first company to introduce whole genome sequencing and interpretation to consumers and their physicians, leads by relentlessly pushing the boundaries of science and technology while driving down the cost of the genome. http://www.veritasint.com